EN
Pharma Delegates conducts its meetings at noon on the third Wednesday of each month at the Tokyo American Club. Speakers have included Ministry officials, industry leaders in Japan and from overseas, science and technology experts, R&D executives, physicians, hospital pharmacists, HR specialists, CRO experts, academics, market researchers, industry analysts, economists, wholesalers and other entrepreneurs. Pharma Delegates conducts its meetings at noon on the third Wednesday of each month at the Tokyo American Club. Speakers have included Ministry officials, industry leaders in Japan and from overseas, science and technology experts, R&D executives, physicians, hospital pharmacists, HR specialists, CRO experts, academics, market researchers, industry analysts, economists, wholesalers and other entrepreneurs.
| YEAR | DATE | Title and Speaker |
|---|---|---|
| 2024 | 11 Sep. | Dr. Satoshi Ezoe, Deputy Assistant Minister for Global Health, MHLW. “ Japan’s Global Health Diplomacy: A view from health diplomat ” |
| 2024 | 22 Oct. | Dr. Masato Iwasaki, Senior Executive Fellow, Industrial Growth Platform, Inc. “Outlook of the future healthcare system in Japan and expectations to the pharmaceutical industry” |
| 2024 | 20 Nov. | Dr. Yuanzhong Li, Senior Research Manager, Bioscience & Engineering laboratories, FUJIFILM Corporation “AI advances and FUJIFILM’s initiatives in healthcare” |
| 2024 | 11 Dec. | Dr. Kenichi Oi ,Program Director, CANCER SUPPORT COMMUNITY JAPAN “Advancing Health Equity in Cancer Care and Work to Reduce Cancer Disparities: Multi-Partnership-led Grassroots Advocacy” |
| 2025 | 15 Jan. | Mr. Rodrigo González, Ph.D., North Asia Director, Economist Intelligence Corporate Network(EICN)E “EICN Executive Briefing” |
| 2025 | 19 Feb. | Mr. James Feliciano, Senior Advisor, AbbVie Japan Mr. Glen Argyle, President and Representative Director, Baxter Japan K.K. Mr. Jeremy Grossas, President and Representative Director, Merck Biopharma Japan Panel discussion : “Digital Engagement with HCPs: Strategic Imperatives for Pharma Leadership” |
| 2025 | 21 Mar. | Mr. Hiroaki Ueno, Ph.D.,President of Japan Pharmaceutical Manufacturers Association（JPMA）. Representative Director, Mitsubishi Tanabe Pharma Corporation “Strengthening Drug Discovery Capabilities in Japan" |
| 2025 | 16 Apr. | Prof. Toshio Miyata, Center for Translational and Advanced Research, Tohoku University Graduate School of Medicine “A drug from academia helps fight cancer and aging” |
| 2025 | 15 May. | Mr. Alan Thomas, Senior Director, IQVIA Solutions Japan K.K. “Japan Pharma Market Dynamics - Update on 2024 and Outlook to 2029” |
| 2025 | 30. June. | Year-end Special Seminar Mr. Osamu Kunii, MD, MPH, PhD Chief Executive Officer (CEO), Global Health Innovative Technology Fund (GHIT Fund) “The Past and Future of Global Health Issues, Architecture, and Solutions” |
EN